학술논문
Antibody and T Cell Responses against SARS-CoV-2 Elicited by the Third Dose of BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) Vaccines Using a Homologous or Heterologous Booster Vaccination Strategy
Document Type
Article
Author
Source
In: Vaccines . (Vaccines, April 2022, 10(4))
Subject
Language
English
ISSN
2076393X